Abstract
We present a new protocol aimed at the structure-based design of drug-like molecules using a fragment approach. It starts from a suitably placed and well-defined “base fragment” and then uses an incremental construction algorithm and a scoring function to grow the molecule into prioritized candidates. The selection of the most promising solutions for synthesis and validation is guided by the optimization of the calculated ligand efficiency indices known as binding efficiency index (BEI) and surface efficiency index (SEI), which allow the user to navigate proficiently in chemico-biological space. A test case for the protocol is exemplified here using published data for inhibitors of protein kinase B, aka AKT, a key enzyme in several signal transduction pathways. Our procedure was able to identify the main features responsible for the binding of inhibitors and guided the selection process towards molecules that included or resembled those shown as the most active in the original studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murray CW, Rees DC (2009) The rise of fragment-based drug discovery. Nat Chem 1:187–192
Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) Recent developments in fragment-based drug discovery. J Med Chem 51:3661–3680
Congreve M, Carr R, Murray C, Jhoti H (2003) A “rule of three” for fragment-based lead discovery? Drug Discov Today 8:876–877
Jhoti H, Williams G, Rees DC, Murray CW (2013) The ‘rule of three’ for fragment-based drug discovery: where are we now? Nat Rev Drug Discov 12:644
Reynolds CH, Tounge BA, Bembenek SD (2008) Ligand binding efficiency: trends, physical basis, and implications. J Med Chem 51:2432–2438
Abad-Zapatero C (2013) Ligand efficiency indices for drug discovery. Academic Press London
Bembenek SD, Tounge BA, Reynolds CH (2009) Ligand efficiency and fragment-based drug discovery. Drug Discov Today 14:278–283
Abad-Zapatero C, Blasi D (2011) Ligand efficiency indices (LEIs): more than a simple efficiency yardstick. Mol Informatics 30:122–132
Blasi D, Arsequell G, Valencia G, Nieto J, Planas A, Pinto M et al (2011) Retrospective mapping of SAR data for TTR protein in chemico-biological space using ligand efficiency indices as a guide to drug discovery strategies. Mol Informatics 30:161–167
Tanaka D, Tsuda Y, Shiyama T, Nishimura T, Chiyo N, Tominaga Y et al (2010) A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors. J Med Chem 54:851–857
Schrodinger L. PyMOL molecular graphics system, version 1.5. 0.4. See http://pymol.org
Saxty G, Woodhead SJ, Berdini V, Davies TG, Verdonk ML, Wyatt PG et al (2007) Identification of inhibitors of protein kinase B using fragment-based lead discovery. J Med Chem 50:2293–2296
Goodford PJ (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28:849–857
Klett J, Nuñez-Salgado A, Dos Santos HG, Cortés-Cabrera Á, Perona A, Gil-Redondo R et al (2012) MM-ISMSA: an ultrafast and accurate scoring function for protein-protein docking. J Chem Theor Comput 8:3395–3408
Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP (1997) Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des 11:425–445
Schneider N, Lange G, Hindle S, Klein R, Rarey M (2013) A consistent description of HYdrogen bond and DEhydration energies in protein-ligand complexes: methods behind the HYDE scoring function. J Comput Aided Mol Des 27:15–29
Abad-Zapatero C (2007) Ligand efficiency indices for effective drug discovery. Expert Opin Drug Discov 2:469–488
Gill A, Cleasby A, Jhoti H (2005) The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography. Chembiochem 6:506–512
Boobbyer DN, Goodford PJ, McWhinnie PM, Wade RC (1989) New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure. J Med Chem 32:1083–1094
Treiber DK, Shah NP (2013) Ins and outs of kinase DFG motifs. Chem Biol 20:745–746
O'Boyle NM, Morley C, Hutchison GR (2008) Pybel: a python wrapper for the OpenBabel cheminformatics toolkit. Chem Cent J 2:5
Weininger D (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28:31–36
Sadowski J, Gasteiger J, Klebe G (1994) Comparison of automatic three-dimensional model builders using 639 X-ray structures. J Chem Inf Comput Sci 34:1000–1008
Morreale A, Gil-Redondo R, Ortiz AR (2007) A new implicit solvent model for protein-ligand docking. Proteins Struct Funct Bioinf 67:606–616
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749
Warren GL, Andrews CW, Capelli A-M, Clarke B, LaLonde J, Lambert MH et al (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49:5912–5931
Reulecke I, Lange G, Albrecht J, Klein R, Rarey M (2008) Towards an integrated description of hydrogen bonding and dehydration: decreasing false positives in virtual screening with the HYDE scoring function. ChemMedChem 3:885–897
Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G et al (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35:W522–W525
Brenk R, Naerum L, Gradler U, Gerber HD, Garcia GA, Reuter K et al (2003) Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis. J Med Chem 46:1133–1143
Cross JB, Thompson DC, Rai BK, Baber JC, Fan KY, Hu Y et al (2009) Comparison of several molecular docking programs: pose prediction and virtual screening accuracy. J Chem Inf Model 49:1455–1474
O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3:33
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174
Tanford C (1978) The hydrophobic effect and the organization of living matter. Science 200:1012–1018
Ruppert J, Welch W, Jain AN (1997) Automatic identification and representation of protein binding sites for molecular docking. Proc Natl Acad Sci U S A 6:524–533
Nelder JA, Mead R (1965) A simplex method for function minimization. Comput J 7:308–313
Acknowledgement
This work was supported by grants from CICYT (SAF2009-13914-C02-02 to F.G. and SAF2012-39760-C02-02 to F.G. and A.M.) and Comunidad Autónoma de Madrid (S-BIO-0214-2006 [BIPEDD] and S2010-BMD-2457 [BIPEDD-2] to A.M. and F.G.). A.M. acknowledges financial support from Fundación Severo Ochoa through the AMAROUTO program. A.C.C. is the recipient of an FPU grant (ref. AP2009-0203) from the Spanish Ministerio de Educación.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Cortés-Cabrera, Á., Gago, F., Morreale, A. (2015). A Computational Fragment-Based De Novo Design Protocol Guided by Ligand Efficiency Indices (LEI). In: Klon, A. (eds) Fragment-Based Methods in Drug Discovery. Methods in Molecular Biology, vol 1289. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2486-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2486-8_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2485-1
Online ISBN: 978-1-4939-2486-8
eBook Packages: Springer Protocols